Back to Search Start Over

NCCN GuidelinesĀ® Insights: Ovarian Cancer, Version 3.2022.

Authors :
Armstrong DK
Alvarez RD
Backes FJ
Bakkum-Gamez JN
Barroilhet L
Behbakht K
Berchuck A
Chen LM
Chitiyo VC
Cristea M
DeRosa M
Eisenhauer EL
Gershenson DM
Gray HJ
Grisham R
Hakam A
Jain A
Karam A
Konecny GE
Leath CA III
Leiserowitz G
Liu J
Martin L
Matei D
McHale M
McLean K
Miller DS
Percac-Lima S
Remmenga SW
Schorge J
Stewart D
Thaker PH
Vargas R
Hendrickson AW
Werner TL
Zsiros E
Dwyer MA
Hang L
Source :
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Sep; Vol. 20 (9), pp. 972-980.
Publication Year :
2022

Abstract

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living >5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

Details

Language :
English
ISSN :
1540-1413
Volume :
20
Issue :
9
Database :
MEDLINE
Journal :
Journal of the National Comprehensive Cancer Network : JNCCN
Publication Type :
Academic Journal
Accession number :
36075393
Full Text :
https://doi.org/10.6004/jnccn.2022.0047